This week, we explore the rise in Alzheimer’s clinical trials despite recruitment hurdles, as well as the use of artificial intelligence in understanding gene interactions. In addition, we discuss SNIPR Biome’s advances in CRISPR-based antibiotics and Tempus’ launch of a ...

Physicians are facing a growing challenge as they face a surge in demand for their services. Visits per physician office this year have grown by a staggering 30%, far higher than the rate in 2019, before the pandemic, according to ...

This week we highlight a shortage of prescription medication in the United States. In addition, we discuss a Food and Drug Administration committee’s recommendation to approve a new RSV vaccine, comments on the Inflation Reduction Act impact, as well as ...

This week we’re tracking new COVID-19 booster strategies targeting the XBB variant, Moderna’s move into mRNA therapies for rare diseases, U. S. Food and Drug Administration guidelines to safeguard tattoo inks, challenges for European medical device startups, and a Scottish ...

This week we spotlight the significant uptick in biotech layoffs in the first quarter as well as the European Commission’s strategic postponement of the new Medical Device Regulation. Additionally, we delve into recent groundbreaking approvals encompassing two innovative oral medications ...

This week we spotlight the introduction of new pathways for emerging technologies in Medicare coverage and the use of virtual reality to alleviate needle phobia. We also delve into the financial aspects of the biopharma industry, examining the trend of ...